Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for GERD-related Sleep Disturbances
NCT00628342Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2003
- Primary completion
- Aug 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Apr 2003; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00628342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628342.